BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6264257)

  • 1. A new approach to the treatment of atherosclerosis and trapidil as an antagonist to platelet-derived growth factor.
    Ohnishi H; Yamaguchi K; Shimada S; Suzuki Y; Kumagai A
    Life Sci; 1981 Apr; 28(14):1641-6. PubMed ID: 6264257
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence for "response to injury" hypothesis.
    Ohnishi H; Yamaguchi K; Shimada S; Sato M; Funatc H; Katsuki Y; Dabasaki T; Suzuki Y; Saitoh Y; Kumagai A
    Life Sci; 1982 Dec; 31(23):2595-602. PubMed ID: 7154855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The platelet-derived growth factor: a perspective.
    Ross R
    Prog Clin Biol Res; 1981; 66 Pt A():503-6. PubMed ID: 7312873
    [No Abstract]   [Full Text] [Related]  

  • 4. Suppression of fibroblast proliferation in vitro and of myointimal hyperplasia in vivo by the triazolopyrimidine, Trapidil.
    Tiell ML; Sussman II; Gordon PB; Saunders RN
    Artery; 1983; 12(1):33-50. PubMed ID: 6678578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelets: cell proliferation and atherosclerosis.
    Ross R
    Metabolism; 1979 Apr; 28(4 Suppl 1):410-4. PubMed ID: 122294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet and endothelial response with trapidil in patients with peripheral obliterative arteriopathy.
    Bonfardeci G; Cimminiello C; Cantini L; Arpaia G; Aloisio M; Pozzi F
    Int Angiol; 1994 Dec; 13(4):339-42. PubMed ID: 7790757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of platelet-inhibiting drugs in models of atherosclerosis.
    Saunders RN
    Annu Rev Pharmacol Toxicol; 1982; 22():279-95. PubMed ID: 7044286
    [No Abstract]   [Full Text] [Related]  

  • 8. Mammalian cell proliferation is regulated by the synergistic actions of multiple growth factors.
    Pledger WJ; Hart CA; Wharton WR
    Adv Exp Med Biol; 1981; 138():287-300. PubMed ID: 7200718
    [No Abstract]   [Full Text] [Related]  

  • 9. Fibroblast growth factor can substitute for platelet factor to sustain the growth of Balb/3T3 cells in the presence of plasma.
    Gospodarowicz D; Greene G; Moran J
    Biochem Biophys Res Commun; 1975 Jul; 65(2):779-87. PubMed ID: 1170869
    [No Abstract]   [Full Text] [Related]  

  • 10. A mitogenic factor for transformed cells from human platelets.
    Lipton A; Kepner N; Rogers C; Witkoski E; Leitzel K
    Prog Clin Biol Res; 1982; 89():233-48. PubMed ID: 6287487
    [No Abstract]   [Full Text] [Related]  

  • 11. The regulation of cell proliferation by serum growth factors.
    Pledger WJ; Howe PH; Leof EB
    Ann N Y Acad Sci; 1982 Dec; 397():1-10. PubMed ID: 6961836
    [No Abstract]   [Full Text] [Related]  

  • 12. Cell transformation mutants are not susceptible to growth activation by fibroblast growth factor at permissive temperatures.
    Rudland PS; Eckhart W; Gospodarowicz D; Seifert W
    Nature; 1974 Jul; 250(464):337-9. PubMed ID: 4368479
    [No Abstract]   [Full Text] [Related]  

  • 13. The arterial wall and atherosclerosis.
    Ross R
    Annu Rev Med; 1979; 30():1-15. PubMed ID: 122258
    [No Abstract]   [Full Text] [Related]  

  • 14. Similarities between fibroblast-derived growth factor and platelet-derived growth factor.
    Dicker P; Pohjanpelto P; Pettican P; Rozengurt E
    Exp Cell Res; 1981 Sep; 135(1):221-7. PubMed ID: 6456922
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiproliferative effect of trapidil, a platelet-derived growth factor antagonist, on a glioma cell line in vitro.
    Kuratsu J; Ushio Y
    J Neurosurg; 1990 Sep; 73(3):436-40. PubMed ID: 2384782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-derived growth factor and the regulation of the mammalian fibroblast cell cycle.
    Scher CD; Shepard RC; Antoniades HN; Stiles CD
    Biochim Biophys Acta; 1979 Aug; 560(2):217-41. PubMed ID: 380651
    [No Abstract]   [Full Text] [Related]  

  • 17. Human platelet-derived growth factor: structure and function.
    Antoniades HN; Williams LT
    Fed Proc; 1983 Jun; 42(9):2630-4. PubMed ID: 6303866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the platelet-derived growth factor antagonist trapidil on mesangial cell proliferation in rats.
    Futamura A; Izumino K; Nakagawa Y; Takata M; Inoue H; Iida H
    Nephron; 1999; 81(4):428-33. PubMed ID: 10095179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of cytolysis of BALB/c-3T3 cells by platelet-derived growth factor: a model system for analyzing cell death.
    Scher CD; Young SA; Locatell KL
    J Cell Physiol; 1982 Nov; 113(2):211-8. PubMed ID: 6217213
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of the antianginal drug trapidil and its derivative AR 12463 on arachidonic acid liberation and thromboxane formation in thrombin-stimulated platelets.
    Block HU; Dunemann A; Niebisch M; Mest HJ
    Biomed Biochim Acta; 1988; 47(10-11):S141-4. PubMed ID: 3248101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.